Nicholas Grund
Corporate Officer/Principal presso AKEBIA THERAPEUTICS, INC.
Patrimonio netto: 403 389 $ in data 30/04/2024
Posizioni attive di Nicholas Grund
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | 09/01/2024 | - |
Storia della carriera di Nicholas Grund
Precedenti posizioni note di Nicholas Grund
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Transplant Genomics, Inc.
 Transplant Genomics, Inc. BiotechnologyHealth Technology Transplant Genomics, Inc. operates as a molecular diagnostic company. It develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes and enable optimization of therapy. The company was founded by Daniel Salomon in 2013 and is headquartered in Mansfield, MA. | Corporate Officer/Principal | 01/01/2021 | 01/11/2022 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 04/01/2016 | 29/03/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2007 | 01/12/2015 |
| Bayer Diagnostics Corp. | Corporate Officer/Principal | 01/01/1995 | 01/01/2002 |
Formazione di Nicholas Grund
| University of Massachusetts | Undergraduate Degree |
| Northeastern University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Transplant Genomics, Inc.
Transplant Genomics, Inc. BiotechnologyHealth Technology Transplant Genomics, Inc. operates as a molecular diagnostic company. It develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes and enable optimization of therapy. The company was founded by Daniel Salomon in 2013 and is headquartered in Mansfield, MA. | Health Technology |
| Bayer Diagnostics Corp. | Health Technology |
- Borsa valori
- Insiders
- Nicholas Grund
- Esperienza
